🔎 Trials Near Me

Inicio › Enfermedad de Crohn › Oklahoma

Ensayos clínicos de Enfermedad de Crohn en Oklahoma

8 estudios sobre Enfermedad de Crohn buscan participantes en Oklahoma.

Ciudades en Oklahoma

Texto oficial del estudio (inglés)

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Digestive Disease Specialists Inc. ( Site 5117), Oklahoma City
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Digestive Disease Specialists - Oklahoma /ID# 265901, Oklahoma City
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  • Digestive Disease Specialists Inc, Oklahoma City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07499232

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Central Sooner Research-Site Number: 8400094, Norman
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07184931

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • Digestive Disease Specialists, Inc., Oklahoma City
ReclutandoFase 4
Edades de 18 a 70 · Todos los sexos · Actualizado el 9 sept 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  • Digestive Disease Specialists Inc, Oklahoma City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07577843

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  • The University of Oklahoma Health Sciences Center, Oklahoma City
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06100289

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • The University of Oklahoma Health Sciences Center, Oklahoma City
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06405087

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.